D-0004-2022 Class II Terminated

Recalled by Akorn, Inc. — Lake Forest, IL

FDA drug recall D-0004-2022 was initiated by Akorn, Inc. on Oct 4, 2021 and is designated Class II. Reason for recall: Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point. The recall status is terminated (terminated Aug 17, 2022). Affected quantity: 10,210 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 13, 2021
Initiation Date
Oct 4, 2021
Termination Date
Aug 17, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10,210 bottles

Product description

Betaxolol Ophthalmic Solution, USP, 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL dropper bottle, Rx only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. Carton NDC: 17478-705-10, Bottle NDC 17478-705-11

Reason for recall

Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot 0B61A, Exp 01/31/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0004-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0004-2022. Report a data issue: hello@regdatalab.com.